Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
(NASDAQ:PBYI) LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on September 2, 2025, the Compensation Committee of Puma’s Board of ...
7 days ago